Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: Preliminary report of an open trial

Sung Il Jung, Cheong Hoon Seo, Kiun Jang, Byung-Joo Ham, Ihn Geun Choi, Jong Hyun Kim, Boung Chul Lee

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Pruritis (itching) constitutes a source of severe distress for burn patients. The authors administered naltrexone to burn patients suffering from itching that was refractory to treatment with antihistamine and anticonvulsant medications to examine the efficacy of this medication as a treatment for pruritis in burn patients. Nineteen burn patients admitted to the Hailym Burn Center at Hangang Sacred Heart Hospital in Seoul, Korea, with burns over 40.32% (±18.3) of their total body surface were recruited for this study. The mean number of postburn days before naltrexone treatment was 157.3 days (±114.7). The authors observed a significant decrease in itching sensations after 2 weeks of treatment with naltrexone (z = -3.32, P = .001). Scratching activity was also decreased in 44.5% (±20.5) of subjects. The authors propose that naltrexone constitutes a potential antipruritk medication for burn patients suffering from treatment-refractory itching.

Original languageEnglish
Pages (from-to)257-260
Number of pages4
JournalJournal of Burn Care and Research
Volume30
Issue number2
DOIs
Publication statusPublished - 2009 Mar 1
Externally publishedYes

Fingerprint

Naltrexone
Pruritus
Therapeutics
Burn Units
Histamine Antagonists
Korea
Burns
Anticonvulsants

ASJC Scopus subject areas

  • Emergency Medicine
  • Rehabilitation
  • Surgery

Cite this

Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients : Preliminary report of an open trial. / Jung, Sung Il; Seo, Cheong Hoon; Jang, Kiun; Ham, Byung-Joo; Choi, Ihn Geun; Kim, Jong Hyun; Lee, Boung Chul.

In: Journal of Burn Care and Research, Vol. 30, No. 2, 01.03.2009, p. 257-260.

Research output: Contribution to journalArticle

Jung, Sung Il ; Seo, Cheong Hoon ; Jang, Kiun ; Ham, Byung-Joo ; Choi, Ihn Geun ; Kim, Jong Hyun ; Lee, Boung Chul. / Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients : Preliminary report of an open trial. In: Journal of Burn Care and Research. 2009 ; Vol. 30, No. 2. pp. 257-260.
@article{c91d0ce35be940f79df7b6f6cadb464c,
title = "Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients: Preliminary report of an open trial",
abstract = "Pruritis (itching) constitutes a source of severe distress for burn patients. The authors administered naltrexone to burn patients suffering from itching that was refractory to treatment with antihistamine and anticonvulsant medications to examine the efficacy of this medication as a treatment for pruritis in burn patients. Nineteen burn patients admitted to the Hailym Burn Center at Hangang Sacred Heart Hospital in Seoul, Korea, with burns over 40.32{\%} (±18.3) of their total body surface were recruited for this study. The mean number of postburn days before naltrexone treatment was 157.3 days (±114.7). The authors observed a significant decrease in itching sensations after 2 weeks of treatment with naltrexone (z = -3.32, P = .001). Scratching activity was also decreased in 44.5{\%} (±20.5) of subjects. The authors propose that naltrexone constitutes a potential antipruritk medication for burn patients suffering from treatment-refractory itching.",
author = "Jung, {Sung Il} and Seo, {Cheong Hoon} and Kiun Jang and Byung-Joo Ham and Choi, {Ihn Geun} and Kim, {Jong Hyun} and Lee, {Boung Chul}",
year = "2009",
month = "3",
day = "1",
doi = "10.1097/BCR.0b013e318198a282",
language = "English",
volume = "30",
pages = "257--260",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Efficacy of naltrexone in the treatment of chronic refractory itching in burn patients

T2 - Preliminary report of an open trial

AU - Jung, Sung Il

AU - Seo, Cheong Hoon

AU - Jang, Kiun

AU - Ham, Byung-Joo

AU - Choi, Ihn Geun

AU - Kim, Jong Hyun

AU - Lee, Boung Chul

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Pruritis (itching) constitutes a source of severe distress for burn patients. The authors administered naltrexone to burn patients suffering from itching that was refractory to treatment with antihistamine and anticonvulsant medications to examine the efficacy of this medication as a treatment for pruritis in burn patients. Nineteen burn patients admitted to the Hailym Burn Center at Hangang Sacred Heart Hospital in Seoul, Korea, with burns over 40.32% (±18.3) of their total body surface were recruited for this study. The mean number of postburn days before naltrexone treatment was 157.3 days (±114.7). The authors observed a significant decrease in itching sensations after 2 weeks of treatment with naltrexone (z = -3.32, P = .001). Scratching activity was also decreased in 44.5% (±20.5) of subjects. The authors propose that naltrexone constitutes a potential antipruritk medication for burn patients suffering from treatment-refractory itching.

AB - Pruritis (itching) constitutes a source of severe distress for burn patients. The authors administered naltrexone to burn patients suffering from itching that was refractory to treatment with antihistamine and anticonvulsant medications to examine the efficacy of this medication as a treatment for pruritis in burn patients. Nineteen burn patients admitted to the Hailym Burn Center at Hangang Sacred Heart Hospital in Seoul, Korea, with burns over 40.32% (±18.3) of their total body surface were recruited for this study. The mean number of postburn days before naltrexone treatment was 157.3 days (±114.7). The authors observed a significant decrease in itching sensations after 2 weeks of treatment with naltrexone (z = -3.32, P = .001). Scratching activity was also decreased in 44.5% (±20.5) of subjects. The authors propose that naltrexone constitutes a potential antipruritk medication for burn patients suffering from treatment-refractory itching.

UR - http://www.scopus.com/inward/record.url?scp=62549120291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549120291&partnerID=8YFLogxK

U2 - 10.1097/BCR.0b013e318198a282

DO - 10.1097/BCR.0b013e318198a282

M3 - Article

C2 - 19165115

AN - SCOPUS:62549120291

VL - 30

SP - 257

EP - 260

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 2

ER -